microRNAs: Key Players in Hematopoiesis
- PMID: 26662992
- DOI: 10.1007/978-3-319-22380-3_10
microRNAs: Key Players in Hematopoiesis
Abstract
microRNAs (miRNAs) are small length noncoding RNAs which play a key role in cellular processes such as proliferation, differentiation, and development of lineage hematopoietic cells and matured blood cells. Aberrant expression of miRNAs has been reported in several hematopoietic disorders. The involvement of miRNAs in regulation of various signaling pathways has been shown in hematopoietic disorders. Along with regulatory role, miRNAs are also proven as diagnostic and prognostic markers for these malignancies. Recent studies are evidenced that the miRNA are key regulators of hematopoietic disorders and progression of these disorders shows the importance of targeting the aberrant expression of miRNAs as new therapeutic interventions. The present chapter provides overview of the art related to the importance of miRNAs in developmental hematopoiesis and pathogenesis of hematopoietic disorders including chronic lymphocytic leukemia, chronic myelogenous leukemia, multiple myelomas, and B cell lymphomas.
Keywords: B cell lymphomas; Chronic lymphocytic leukemia; Chronic myelogenous leukemia; Hematopoietic disorders; Multiple myelomas; miRNA.
Similar articles
-
miRNAs in Normal and Malignant Hematopoiesis.Int J Mol Sci. 2017 Jul 11;18(7):1495. doi: 10.3390/ijms18071495. Int J Mol Sci. 2017. PMID: 28696359 Free PMC article. Review.
-
Regulation of the MIR155 host gene in physiological and pathological processes.Gene. 2013 Dec 10;532(1):1-12. doi: 10.1016/j.gene.2012.12.009. Epub 2012 Dec 14. Gene. 2013. PMID: 23246696 Review.
-
MicroRNAs in the ontogeny of leukemias and lymphomas.Leuk Lymphoma. 2009 Feb;50(2):160-70. doi: 10.1080/10428190802535114. Leuk Lymphoma. 2009. PMID: 19160125 Review.
-
Methylation of tumor suppressor microRNAs: lessons from lymphoid malignancies.Expert Rev Mol Diagn. 2012 Sep;12(7):755-65. doi: 10.1586/erm.12.64. Expert Rev Mol Diagn. 2012. PMID: 23153241 Review.
-
Pathogenesis of early leukemia and lymphoma.Cancer Biomark. 2010;9(1-6):341-74. doi: 10.3233/CBM-2011-0178. Cancer Biomark. 2010. PMID: 22112484 Review.
Cited by
-
Non-coding RNAs: are they the protagonist or antagonist in the regulation of leukemia?Am J Transl Res. 2022 Mar 15;14(3):1406-1432. eCollection 2022. Am J Transl Res. 2022. PMID: 35422954 Free PMC article. Review.
-
Effects of miR‑210‑3p on the erythroid differentiation of K562 cells under hypoxia.Mol Med Rep. 2021 Aug;24(2):563. doi: 10.3892/mmr.2021.12202. Epub 2021 Jun 10. Mol Med Rep. 2021. PMID: 34109429 Free PMC article.
-
Megakaryoblastic leukemia: a study on novel role of clinically significant long non-coding RNA signatures in megakaryocyte development during treatment with phorbol ester.Cancer Immunol Immunother. 2021 Dec;70(12):3477-3488. doi: 10.1007/s00262-021-02937-0. Epub 2021 Apr 23. Cancer Immunol Immunother. 2021. PMID: 33890137 Free PMC article.
-
Elevation of Circulating miR-210-3p in High-Altitude Hypoxic Environment.Front Physiol. 2016 Mar 8;7:84. doi: 10.3389/fphys.2016.00084. eCollection 2016. Front Physiol. 2016. PMID: 27014085 Free PMC article.
-
MicroRNA-9 promotes cell proliferation by regulating RUNX1 expression in human megakaryocyte development.Cell Prolif. 2018 Feb;51(1):e12414. doi: 10.1111/cpr.12414. Epub 2017 Nov 28. Cell Prolif. 2018. PMID: 29193421 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical